The invention provides a crystalline anhydrate of tiotropium bromide, amethod for producing said anhydrate and the use thereof for producing amedicamentfor the treatment of respiratory tract diseases, in particular, for thetreatment ofchronic obstructive pulmonary disease (COPD) and asthma. In a methodembodiment, the crystalline anhydrate is obtained from the monohydrate oftiotropiumbromide.